| mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
3e-06 |
| mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
5e-06 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
| mRNA |
CAL-101 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
2e-05 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-05 |
| mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
| mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
3e-05 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
6e-05 |
| mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
6e-05 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
7e-05 |